中文名 |
(PYR5)-SUBSTANCE P (5-11) |
---|---|
英文名 |
N-[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[(5-oxopyrrolidine-2-carbonyl)amino]pentanediamide |
英文别名 |
更多 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 1374.9±65.0 °C at 760 mmHg |
分子式 | C41H57N9O9S |
分子量 | 852.011 |
闪点 | 785.3±34.3 °C |
精确质量 | 851.400024 |
PSA | 315.18000 |
LogP | 0.64 |
蒸汽压 | 0.0±0.3 mmHg at 25°C |
折射率 | 1.581 |
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
Biological activity of C-terminal partial sequences of substance P. J. Med. Chem. 19 , 854, (1976)
Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2) and the C-terminal partial sequences down to the tripeptide were synthesized by a solid-phase method. These peptides were assayed for vaso…
|
|
5-Oxo-L-prolyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-L-methioninamide |
[pGlu5]-Substance P Fragment 5-11 |
pGlu-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
L-Methioninamide, 5-oxo-L-prolyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl- |